CASSANDRA PHILLIPS: Open Payments
NPI 1366185399 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 75 payments from 11 companies in 2025. Trend: 2023 $1,412 · 2024 $1,036 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $203 |
| E.R. Squibb & Sons, L.L.C. | 18 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $154 |
| Alkermes, Inc. | 12 | $153 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Corium, LLC | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Lundbeck LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: COBENFY, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII, REXULTI, FANAPT, Auvelity, Azstarys.
Industry payments across IN — which companies pay providers there.
